免疫球蛋白G的N-糖基化特征与新发2型糖尿病及心血管疾病的关联
在EPIC-Potsdam队列的病例-队列研究中,采用超高效液相色谱检测24个IgG N-糖基峰并衍生8个糖基化特征。基于5个IgG-GP的评分与新发2型糖尿病风险升高相关,汇总估计每SD增加为1.50(95%CI 1.37-1.64);IgG-GP与心血管疾病风险的关联存在性别差异。
要点
- IgG-GP7、GP8、GP9、GP11、GP19与2型糖尿病风险相关。
- 基于上述5个IgG-GP的评分与糖尿病风险升高相关,汇总每SD增加1.50(95%CI 1.37-1.64)。
- 女性中IgG-GP9与心血管疾病风险呈负相关(HR每SD 0.80,95%CI 0.65-0.98),男性中基于GP19和GP23的加权评分与心血管疾病风险升高相关(HR每SD 1.47,95%CI 1.20-1.80)。
核心结论
- 选定的IgG N-糖链与心脏代谢风险相关,且独立于经典风险因素(包括临床生物标志物)。
研究设计与样本
- 在基于人群的欧洲癌症与营养前瞻性调查(EPIC)-Potsdam队列中开展病例-队列研究,2型糖尿病亚队列2127人(741例新发病例),心血管疾病亚队列2175人(417例心肌梗死和卒中病例)。
- 采用超高效液相色谱测量24个IgG N-糖基峰(IgG-GPs)的相对丰度,并基于结构相似性衍生8个糖基化特征。
- 用分数多项式预选与终点相关的IgG-GPs,在混杂因素校正的Cox模型中估计前瞻性关联,糖尿病风险关联在3项独立研究中验证。
主要发现
- 经混杂因素校正和多重检验校正后,IgG-GP7、IgG-GP8、IgG-GP9、IgG-GP11和IgG-GP19与2型糖尿病风险相关。
- 基于这些IgG-GPs的评分在EPIC-Potsdam和独立验证研究中与更高的糖尿病风险相关(总计843例病例、3149例非病例,汇总估计每SD增加1.50 [95%CI 1.37-1.64])。
- IgG-GPs与心血管疾病风险的关联在男女之间不同;女性中IgG-GP9与心血管疾病风险呈负相关(HR每SD 0.80 [95%CI 0.65-0.98]),男性中基于IgG-GP19和IgG-GP23的加权评分与更高的心血管疾病风险相关(HR每SD 1.47 [95%CI 1.20-1.80])。
- 此外,若干衍生特征与心脏代谢疾病发生率相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: N-glycosylation is a functional posttranslational modification of immunoglobulins (Igs). We hypothesized that specific IgG N-glycans are associated with incident type 2 diabetes and cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS: We performed case-cohort studies within the population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort (2,127 in the type 2 diabetes subcohort [741 incident cases]; 2,175 in the CVD subcohort [417 myocardial infarction and stroke cases]). Relative abundances of 24 IgG N-glycan peaks (IgG-GPs) were measured by ultraperformance liquid chromatography, and eight glycosylation traits were derived based on structural similarity. End point-associated IgG-GPs were preselected with fractional polynomials, and prospective associations were estimated in confounder-adjusted Cox models. Diabetes risk associations were validated in three independent studies. RESULTS: After adjustment for confounders and multiple testing correction, IgG-GP7, IgG-GP8, IgG-GP9, IgG-GP11, and IgG-GP19 were associated with type 2 diabetes risk. A score based on these IgG-GPs was associated with a higher diabetes risk in EPIC-Potsdam and independent validation studies (843 total cases, 3,149 total non-cases, pooled estimate per SD increase 1.50 [95% CI 1.37-1.64]). Associations of IgG-GPs with CVD risk differed between men and women. In women, IgG-GP9 was inversely associated with CVD risk (hazard ratio [HR] per SD 0.80 [95% CI 0.65-0.98]). In men, a weighted score based on IgG-GP19 and IgG-GP23 was associated with higher CVD risk (HR per SD 1.47 [95% CI 1.20-1.80]). In addition, several derived traits were associated with cardiometabolic disease incidence. CONCLUSIONS: Selected IgG N-glycans are associated with cardiometabolic risk beyond classic risk factors, including clinical biomarkers.
引用
- Birukov A, Plavša B, Eichelmann F, et al. Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease. Diabetes Care. 2022. PMID: 36174116. doi:10.2337/dc22-0833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。